Bio Key International (BKYI) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $2.63, -10.85% vs the prior close of $2.95.
- Volume 342.38K shares, 0.1x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
BKYI slides 10.8% to $2.63. Closed at $2.63, -10.85% vs the prior close of $2.95. Day range $2.51β$3.11, opened at $3.11.
BKYI daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β BKYI slides 10.8% to $2.63
- Closed at $2.63, -10.85% vs the prior close of $2.95. Day range $2.51β$3.11, opened at $3.11.
- Volume was 342.38K shares, 0.1x its 50-day average of 5.25M β lighter than usual.
- Price is -3.9% vs its 50-day average ($2.74) and -44.3% vs its 200-day average ($4.72).
- 52-week range $1.55β$19.70; today's close sits at 6% of that range, 86.6% below the 52-week high.
Oct 15, 2026 β BKYI rises 1.4% to $2.95, 3 up days in a row
- Closed at $2.95, +1.37% vs the prior close of $2.91. Day range $2.71β$3.55, opened at $2.77.
- Volume was 1.09M shares, 0.2x its 50-day average of 5.23M β lighter than usual.
- Price is +6.8% vs its 50-day average ($2.76) and -37.8% vs its 200-day average ($4.74).
- 52-week range $1.55β$19.70; today's close sits at 8% of that range, 85.0% below the 52-week high.
- That makes 3 straight gains.
Oct 14, 2026 β BKYI rises 2.8% to $2.91
- Closed at $2.91, +2.83% vs the prior close of $2.83. Day range $2.54β$3.38, opened at $2.56.
- Volume was 2.47M shares, 0.5x its 50-day average of 5.18M β lighter than usual.
- Price is +4.5% vs its 50-day average ($2.79) and -38.8% vs its 200-day average ($4.75).
- 52-week range $1.55β$19.70; today's close sits at 7% of that range, 85.2% below the 52-week high.
Oct 13, 2026 β BKYI jumps 71.5% to $2.83 on 23.1x normal volume
- Closed at $2.83, +71.52% vs the prior close of $1.65. Day range $2.69β$4.30, opened at $4.11.
- Volume was 81.93M shares, 23.1x its 50-day average of 3.54M β unusually heavy trading.
- Price is +0.8% vs its 50-day average ($2.81) and -40.6% vs its 200-day average ($4.77).
- 52-week range $1.55β$19.70; today's close sits at 7% of that range, 85.6% below the 52-week high.
Oct 12, 2026 β BKYI dips 1.2% to $1.65, a 52-week low, 9 down days in a row
- Closed at $1.65, -1.20% vs the prior close of $1.67. Day range $1.55β$1.70, opened at $1.62.
- Volume was 71.80K shares, 0.0x its 50-day average of 3.54M β lighter than usual.
- Price is -41.6% vs its 50-day average ($2.83) and -65.5% vs its 200-day average ($4.79).
- 52-week range $1.55β$19.70; today's close sits at 1% of that range, 91.6% below the 52-week high.
- That makes 9 straight losses.
Oct 9, 2026 β BKYI slides 4.0% to $1.67, a 52-week low, 8 down days in a row
- Closed at $1.67, -4.02% vs the prior close of $1.74. Day range $1.62β$1.75, opened at $1.69.
- Volume was 79.50K shares, 0.0x its 50-day average of 3.54M β lighter than usual.
- Price is -42.0% vs its 50-day average ($2.88) and -65.3% vs its 200-day average ($4.81).
- 52-week range $1.61β$19.70; today's close sits at 0% of that range, 91.5% below the 52-week high.
- That makes 8 straight losses.
- SEC filings that day: S-1.
Oct 8, 2026 β BKYI dips 1.1% to $1.74, 7 down days in a row
- Closed at $1.74, -1.14% vs the prior close of $1.76. Day range $1.61β$1.78, opened at $1.72.
- Volume was 120.50K shares, 0.0x its 50-day average of 3.54M β lighter than usual.
- Price is -40.7% vs its 50-day average ($2.93) and -64.0% vs its 200-day average ($4.83).
- 52-week range $1.61β$19.70; today's close sits at 1% of that range, 91.2% below the 52-week high.
- That makes 7 straight losses.
Oct 7, 2026 β BKYI slides 3.3% to $1.76, 6 down days in a row
- Closed at $1.76, -3.30% vs the prior close of $1.82. Day range $1.71β$1.81, opened at $1.77.
- Volume was 123.80K shares, 0.0x its 50-day average of 3.59M β lighter than usual.
- Price is -41.1% vs its 50-day average ($2.99) and -63.7% vs its 200-day average ($4.85).
- 52-week range $1.63β$19.70; today's close sits at 1% of that range, 91.1% below the 52-week high.
- That makes 6 straight losses.
Oct 6, 2026 β BKYI slides 5.7% to $1.82, 5 down days in a row
- Closed at $1.82, -5.70% vs the prior close of $1.93. Day range $1.76β$1.95, opened at $1.95.
- Volume was 263.60K shares, 0.1x its 50-day average of 3.59M β lighter than usual.
- Price is -40.1% vs its 50-day average ($3.04) and -62.7% vs its 200-day average ($4.88).
- 52-week range $1.63β$19.70; today's close sits at 1% of that range, 90.8% below the 52-week high.
- That makes 5 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 β BKYI slides 9.0% to $1.93, 4 down days in a row
- Closed at $1.93, -8.96% vs the prior close of $2.12. Day range $1.78β$2.24, opened at $1.93.
- Volume was 339.50K shares, 0.1x its 50-day average of 3.58M β lighter than usual.
- Price is -37.7% vs its 50-day average ($3.10) and -60.6% vs its 200-day average ($4.90).
- 52-week range $1.63β$19.70; today's close sits at 2% of that range, 90.2% below the 52-week high.
- That makes 4 straight losses.
Oct 2, 2026 β BKYI slides 7.4% to $2.12, 3 down days in a row
- Closed at $2.12, -7.42% vs the prior close of $2.29. Day range $1.92β$2.32, opened at $2.16.
- Volume was 423.90K shares, 0.1x its 50-day average of 3.57M β lighter than usual.
- Price is -32.7% vs its 50-day average ($3.15) and -57.0% vs its 200-day average ($4.92).
- 52-week range $1.63β$19.70; today's close sits at 3% of that range, 89.2% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
BKYI latest news & SEC filings
Every SEC filing by or about BKYI in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 9, 2026 Β· Form S-1 β Registration statement (S-1)
Registration statement (S-1) β registering new shares, usually for an IPO or offering
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Oct 6, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Oct 6, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
- Item 8.01 β Reported other events the company considers important.
Oct 2, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
Sep 8, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Sep 8, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 8.01 β Reported other events the company considers important.
Aug 24, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Aug 14, 2026 Β· Form PRE 14A β Preliminary proxy statement
Preliminary proxy statement
Aug 14, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 2.02 β Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 13, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 1.01 β Signed a material agreement.
- Item 3.02 β Sold unregistered shares.
Aug 13, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$576.85K (prior year -$1.17M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.56 (prior year -$2.01) (loss narrowed vs Jun 30, 2025)
Jul 24, 2026 Β· Form ARS β Annual report to shareholders
Annual report to shareholders
Jul 24, 2026 Β· Form DEF 14A β Proxy statement
Proxy statement β agenda for the shareholder meeting (board elections, executive pay, votes)
Jul 9, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 4.01 β Changed its outside auditor.
Jul 7, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade BKYI
- Last results release: Aug 14, 2026 (8-K Item 2.02). Previous ones: May 18, 2026, Apr 20, 2026, Mar 31, 2026. Based on that rhythm, the next report is likely around Nov 13, 2026 β an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 13.88% (largest 85.7%). That is a volatile stock.
- Liquidity: about 13.06M shares (β$34.34M) trade per day on average.
- 52-week position: $2.63 vs a range of $1.55β$19.70 (6% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:10 on Apr 30, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 6, 2026; 8-K Oct 2, 2026; 8-K Sep 8, 2026.
- Share count: 1.44M shares outstanding (Aug 11, 2026), -79.1% vs a year earlier β the company has been reducing its share count.
- Listing: Nasdaq Β· industry: Services-Prepackaged Software.
BKYI market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.11 | 3.11 | 2.51 | 2.63 | 342.38K |
| Oct 15, 2026 | 2.77 | 3.55 | 2.71 | 2.95 | 1.11M |
| Oct 14, 2026 | 2.56 | 3.38 | 2.54 | 2.91 | 2.47M |
| Oct 13, 2026 | 4.11 | 4.30 | 2.69 | 2.83 | 81.93M |
| Oct 12, 2026 | 1.62 | 1.70 | 1.55 | 1.65 | 71.80K |
| Oct 9, 2026 | 1.69 | 1.75 | 1.62 | 1.67 | 79.50K |
| Oct 8, 2026 | 1.72 | 1.78 | 1.61 | 1.74 | 120.50K |
| Oct 7, 2026 | 1.77 | 1.81 | 1.71 | 1.76 | 123.80K |
| Oct 6, 2026 | 1.95 | 1.95 | 1.76 | 1.82 | 263.60K |
| Oct 5, 2026 | 1.93 | 2.24 | 1.78 | 1.93 | 339.50K |
| Oct 2, 2026 | 2.16 | 2.32 | 1.92 | 2.12 | 423.90K |
| Oct 1, 2026 | 2.80 | 2.80 | 2.20 | 2.29 | 912.70K |
| Sep 30, 2026 | 2.85 | 3.21 | 2.66 | 2.80 | 2.20M |
| Sep 29, 2026 | 3.37 | 4.66 | 2.70 | 3.12 | 169.59M |
| Sep 28, 2026 | 1.83 | 1.96 | 1.65 | 1.68 | 93.50K |
| Sep 25, 2026 | 2.04 | 2.14 | 1.63 | 1.79 | 179.30K |
| Sep 24, 2026 | 2.37 | 2.38 | 1.97 | 2.04 | 171.60K |
| Sep 23, 2026 | 2.44 | 2.55 | 2.22 | 2.49 | 646.20K |
| Sep 22, 2026 | 2.51 | 2.59 | 2.37 | 2.38 | 40.40K |
| Sep 21, 2026 | 2.51 | 2.66 | 2.47 | 2.47 | 13.60K |
About Bio Key International
Bio Key International (BKYI) is listed on the Nasdaq and classified by the SEC under βServices-Prepackaged Softwareβ. Its business address is in HOLMDEL, NJ. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1019034.
BKYI board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Michael W Depasquale | Chief Executive Officer | Jul 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Michael W Depasquale | Chief Executive Officer | Jul 2, 2026 |
| Mira K Lacous | Chief Technology Officer | Jul 2, 2026 |
| James David Sullivan | Chief Legal Officer | Jul 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BKYI financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-7.16M | -10.77 | $-4.67M |
| Dec 31, 2024 | β | $-4.30M | -20.88 | $-2.91M |
| Dec 31, 2023 | β | $-8.52M | -15.21 | $-3.79M |
| Dec 31, 2022 | β | $-11.91M | -27.26 | $-6.23M |
| Dec 31, 2021 | β | $-5.07M | -0.65 | $-8.98M |
Latest balance sheet: total assets $7.48M, total liabilities $3.15M, cash $1.38M (as of Jun 30, 2026).
BKYI earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 14, 2026 | 8-K Item 2.02 (results) | $3.18 |
| May 18, 2026 | 8-K Item 2.02 (results) | $4.27 |
| Apr 20, 2026 | 8-K Item 2.02 (results) | $6.30 |
| Mar 31, 2026 | 8-K Item 2.02 (results) | $5.30 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $7.00 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $9.50 |
| Aug 13, 2025 | 8-K Item 2.02 (results) | $7.90 |
| May 15, 2025 | 8-K Item 2.02 (results) | $8.50 |
| Mar 27, 2025 | 8-K Item 2.02 (results) | $8.60 |
| Nov 15, 2024 | 8-K Item 2.02 (results) | $9.40 |
| Aug 15, 2024 | 8-K Item 2.02 (results) | β |
| Jun 17, 2024 | 8-K Item 2.02 (results) | β |
Related stocks Β· Services-Prepackaged Software
Microsoft (MSFT)Palantir Technologies (PLTR)Oracle (ORCL)CoreWeave (CRWV)CrowdStrike (CRWD)Salesforce (CRM)Shopify (SHOP)Snowflake (SNOW)ServiceNow (NOW)Twilio (TWLO)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BKYI
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.